[HTML][HTML] Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI

JC Roussel, CJ Moran, EJ Salvaris… - American Journal of …, 2008 - Elsevier
Incompatibility between pig thrombomodulin (TM) and primate thrombin is thought to be an
important factor in the development of microvascular thrombosis in rejecting pig-to-primate …

Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients

…, HF Carton, O Al Habash, O Baron, JC Roussel - Circulation, 2014 - Am Heart Assoc
Background— Structural valve deterioration (SVD) is a major flaw of bioprostheses. Early
SVD has been suspected in the last models of Mitroflow bioprosthesis. We sought to assess …

Replacement myocardial fibrosis in patients with mitral valve prolapse: relation to mitral regurgitation, ventricular remodeling, and arrhythmia

…, K Warin-Fresse, PY Marie, JJ Schott, JC Roussel… - Circulation, 2021 - Am Heart Assoc
Background: Mitral valve prolapse (MVP) is a frequent disease that can be complicated by
mitral regurgitation (MR), heart failure, arterial embolism, rhythm disorders, and death. Left …

Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the …

…, R Cocchieri, B De Mol, JC Roussel… - European Journal of …, 2016 - academic.oup.com
OBJECTIVES The aim of the Cavalier trial was to evaluate the safety and performance of the
Perceval sutureless aortic valve in patients undergoing aortic valve replacement (AVR). We …

The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration

…, Y Takeuchi, X Chen, R Mañez, JC Roussel… - Nature medicine, 2022 - nature.com
Bioprosthetic heart valves (BHVs) are commonly used to replace severely diseased heart
valves but their susceptibility to structural valve degeneration (SVD) limits their use in young …

Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation …

…, T Caus, P Bizouarn, M Vourc'h, JC Roussel… - JAMA, 2022 - jamanetwork.com
Importance The optimal approach to the use of venoarterial extracorporeal membrane
oxygenation (ECMO) during cardiogenic shock is uncertain. Objective To determine whether early …

First clinical use of a bioprosthetic total artificial heart: report of two cases

…, C Latrémouille, B Cholley, DM Smadja, JC Roussel… - The Lancet, 2015 - thelancet.com
Background The development of artificial hearts in patients with end-stage heart disease
have been confronted with the major issues of thromboembolism or haemorrhage. Since …

[HTML][HTML] Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection

C Chauveau, D Bouchet, JC Roussel, P Mathieu… - American Journal of …, 2002 - Elsevier
The hallmark of chronic rejection is the occlusion of the artery lumen by intima hyperplasia as
a consequence of leukocyte infiltration and vascular smooth muscle cell (VSMC) migration …

[HTML][HTML] The sutureless aortic valve at 1 year: a large multicenter cohort study

…, L Conradi, R Cocchieri, B De Mol, JC Roussel… - The Journal of thoracic …, 2016 - Elsevier
Objective Sutureless aortic valve replacement (AVR) offers an alternative to standard AVR
in aortic stenosis. This prospective, single-arm study aimed to demonstrate safety and …

A bioprosthetic total artificial heart for end-stage heart failure: results from a pilot study

…, A Carpentier, P Leprince, JC Roussel… - The Journal of Heart and …, 2018 - Elsevier
Background The electro-hydraulically actuated Carmat total artificial heart (C-TAH) is designed
to replace the heart in patients with end-stage heart failure, either as bridge to transplant …